Table 2 Clinical and treatment characteristics (n = 369)
Characteristics | No. of patients |
|---|---|
Sex (male/female) | 263(71%)/106(29%) |
Age (≥70/<70) | 117(32%)/252(68%) |
Performance status (0/1/2) | 114(31%)/244(66%)/11(3%) |
Stage (IIIA/IIIB) | 234(63%)/135(37%) |
Pathology (squamous/adenocarcinoma/other) | 229(62%)/119(32%)/21(6%) |
CTV location | |
Left/right | 193(52%)/176(48%) |
Upper/lower | 235(64 %)/134(36%) |
Smoking history (yes/no) | 230(62%)/139(38%) |
Response (PR + CR/others) | 280(76%)/89(24%) |
RT (3D-CRT/IMRT) | 288(78%)/81(22%) |
Chemotherapy schedule (concurrent DP/concurrent NP/sequential) | 136(37%)/126(34%)/107(29%) |